Table 2

Rare variant analysis in UKBB and 100K (GEL) whole-genome sequencing datasets provides strong evidence for shared haplotype in all individuals with the c.278_289delTCTGCCCCGAAG insCCGCCTCCT variant

UKBB background frequency
(n with variant/n without)
UKBB frequency in individuals with UMOD c.278_289delTCTGCCCCGAAG insCCGCCTCCT variant
(n with/n total)
P valueGEL background frequency
(n with variant/n without)
GEL frequency in individuals with UMOD c.278_289delTCTGCCCCGAAG insCCGCCTCCT variant
(n with/n total)
P value
16:19727140:AAAAG:A329/1151405/55×10–12 410/7521116/20<1×10−16
16:20420849:T:G424/1147164/51×10–10 228/7507318/20<1×10−16
16:20645695:T:G418/1147223/55×10–7 218/7508318/20<1×10−16
16:20794732:T:A109/1150314/54×10–12 76/7522518/20<1×10−16
  • Five of the nine individuals with c.278_289delTCTGCCCCGAAG insCCGCCTCCT variant in the UKBB had whole-genome sequencing data. Specific rare variants (<0.5% UKBB) in a 1 Mb window around the UMOD indel variant (column 1) were significantly over-represented in carriers of the UMOD variant versus the overall UKBB and 100K cohorts. The location of the variants are shown in figure 3. P values are based on Fisher’s exact test and only one individual from each family was included in the analysis.

  • GEL, Genomics England Limited; 100K, 100,000 Genomes Project; UKBB, UK Biobank; UMOD, uromodulin.